Sign up today and learn more about Celularity Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Celularity Stock
Celularity is a developer of therapies designed to treat autoimmune and degenerative diseases, immuno-oncology and functional regeneration. The company's therapies productize allogeneic cells and tissues derived from the postpartum placenta and have the ability to augment immunity and longevity by amplifying the body's ability to fight disease, heal and regenerate itself, enabling patients to begin treatment more quickly, resulting in a better medical outcome.
Chief Executive Officer
Chief Financial Officer